FIELD: medicine, pulmonology.
SUBSTANCE: invention relates to medicine, namely to to pulmonology and intensive care, and can be used to treat patients with new coronavirus infection (COVID-19). Said method according to the invention includes the diagnosis of infection by obtaining a positive test for the presence of RNA or IgM to SARS-CoV-2 or typical X-ray picture on a computed tomography of the thoracic organs. Then the patient is additionally prescribed acetylsalicylic acid 300 mg on the first day and 150 mg on days 2-21 of illness, clopidogrel 300 mg on the first day and 75 mg on days 2-21 and rivaroxaban 20 mg on days 1-21.
EFFECT: use of the invention ensures an effective treatment of COVID-19 infection in patients of different age groups with minimal side effects.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DETERMINATION OF VON WILLEBRAND FACTOR ACTIVITY AS METHOD FOR LABORATORY DIAGNOSIS OF SEVERITY OF SARS-COV-2 INFECTION | 2020 |
|
RU2746520C1 |
| METHOD FOR QUANTITATIVE ASSESSMENT OF THROMBOCYTE AGGREGATION ACTIVITY IN PATIENTS WITH NEW CORONAVIRAL INFECTION | 2021 |
|
RU2760095C1 |
| METHOD OF TREATING COVID-19 IN CHILDREN AT RISK OF SEVERE CLINICAL COURSE OF DISEASE | 2023 |
|
RU2815303C1 |
| MEFLOQUINE AND COMBINATIONS THEREOF FOR TREATING AND PREVENTING A CORONAVIRUS INFECTION | 2020 |
|
RU2763024C1 |
| APPLICATION OF METHOD FOR ADMINISTRATION OF SODIUM SALT OF 2-METHYLTHIO-6-NITRO-1,2-4-TRIAZOL[5,1-C] -1,2,4-TRIAZIN-7-ONE, DIHYDRATE WITH ANTIVIRAL ACTIVITY, FOR TREATMENT OF CORONAVIRUS INFECTION COVID-19 | 2021 |
|
RU2754532C1 |
| METHOD FOR CHOOSING MANAGEMENT TACTICS FOR PATIENTS AFTER CORONAVIRUS INFECTION COVID-19 IN ORDER TO PREVENT LONG-TERM THROMBOTIC COMPLICATIONS | 2021 |
|
RU2770356C1 |
| USE OF METHOD FOR ADMINISTRATION OF SODIUM SALT OF 2-METHYLTHIO-6-NITRO-1,2-4-TRIAZOLO[5,1-c]-1,2,4-TRIAZINE-7-ONE, DIHYDRATE, HAVING ANTIVIRAL ACTIVITY FOR TREATMENT OF CORONAVIRUS INFECTION COVID-19 | 2020 |
|
RU2774860C2 |
| METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
| METHOD FOR CORRECTING COGNITIVE IMPAIRMENT IN PATIENTS DURING THE PERIOD OF CONVALESCENCE OF CORONAVIRUS INFECTION CASED BY THE SARS-CoV-2 VIRUS | 2022 |
|
RU2801379C1 |
| METHOD FOR TREATMENT OF NEW CORONAVIRUS INFECTION | 2022 |
|
RU2790939C1 |
